Intellego Technologies

Intellego announces cancellation of MoveoMed transaction

MAR

Intellego Technologies [Intellego] announced in October 2025 that its subsidiary Yuvio Technologies [Yuvio] had received an order from MoveoMed GmbH [MoveoMed] valued at EUR 22 million for UV-C disinfection devices to be delivered during 2025. Today MoveoMed informed Intellego, that the order is cancelled.

As a result of the independent forensic investigation that KPMG is conducting in connection with the criminal suspicions directed against the company's former CEO, Intellego has received information that the terms of the order to Yuvio, including payment and delivery terms, were falsified.

“Since the previous CEO was arrested on November 18th, we are turning every stone and all transactions are being reviewed”, says Jacob Laurin, Acting CEO Intellego Technologies AB.

Further information on Intellego’s transactions will follow the independent report from KPMG that will be presented during January, 2026.

Datum 2026-01-03, kl 13:15
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!